|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 397.55 USD | -3.65% |
|
-13.22% | +68.95% |
Quotes 5-day view: Alnylam Pharmaceuticals, Inc.
Delayed Quote Nasdaq| 08/12/2025 | 09/12/2025 | 10/12/2025 | 11/12/2025 | 12/12/2025 | |
|---|---|---|---|---|---|
| Last | 430.02 $ | 415.21 $ | 404.46 $ | 412.63 $ | 397.55 $ |
| Volume | 2,411,635 | 1,610,475 | 1,188,960 | 1,284,788 | 1,659,227 |
| Change | -6.13% | -3.44% | -2.59% | +2.02% | -3.65% |
| Opening | 447.00 $ | 430.45 $ | 416.54 $ | 403.36 $ | 408.86 $ |
| High | 449.78 $ | 433.30 $ | 417.00 $ | 414.22 $ | 410.04 $ |
| Low | 423.45 $ | 412.31 $ | 403.80 $ | 402.22 $ | 387.03 $ |
Performance
| 1 day | -3.65% | ||
| 1 week | -13.22% | ||
| Current month | -11.90% | ||
| 1 month | -11.49% | ||
| 3 months | -14.67% | ||
| 6 months | +29.08% | ||
| Current year | +68.95% | ||
| 1 year | +61.97% | ||
| 3 years | +69.96% | ||
| 5 years | +199.61% | ||
| 10 years | +350.07% |
Volumes
marketsDaily volume
1,659,227
Estimated daily volume
1,659,227
Avg. Volume 20 sessions
1,240,414
Daily volume ratio
1.34
Avg. Volume 20 sessions USD
493,126,585.7
Record volume 1
18,362,420
Record volume 2
16,731,380
Record volume 3
9,611,536
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Capitalization (USD)
52,521,848,345
Net sales (USD)
2,248,243,000
Number of employees
2,230
Sales / Employee (USD)
1,008,181
Free-Float
99.2 %
Free-Float capitalization (USD)
51,055,788,103
Average Daily Capital Traded
0.94%
Indicators
Moving average 5 days
411.97
Moving average 20 days
445.39
Moving average 50 days
453.86
Moving average 100 days
444.62
Price spread / (MMA5)
+3.63%
Price spread / (MMA20)
+12.03%
Price spread / (MMA50)
+14.16%
Price spread / (MMA100)
+11.84%
STIM
RSI 9 days
33.25
RSI 14 days
36.91
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -3.65% | -13.22% | +61.97% | +69.96% | 52.52B | ||
| +1.80% | +1.70% | +30.21% | +182.67% | 920B | ||
| +0.75% | +4.78% | +44.31% | +17.70% | 510B | ||
| -0.29% | -1.22% | +28.81% | +35.46% | 395B | ||
| +0.98% | +0.22% | +24.23% | +5.27% | 340B | ||
| +0.09% | -1.05% | +27.67% | +18.27% | 278B | ||
| +0.21% | -1.05% | +19.91% | +24.70% | 254B | ||
| +1.30% | +0.58% | -1.67% | -10.09% | 249B | ||
| -1.53% | +5.57% | -59.39% | -32.29% | 224B | ||
| +0.11% | -3.68% | +17.41% | +17.19% | 171B | ||
| Average | -0.01% | -0.80% | +19.35% | +32.89% | 339.45B | |
| Weighted average by Cap. | +0.64% | +0.93% | +22.17% | +59.25% |
Historical Quotes: Alnylam Pharmaceuticals, Inc.
| Date | Opening | High | Low | End-of-day | Volume | Change |
|---|
Latest transactions
efb3a13453af2a726f0833.dTiprdHaiYeZvcftv-V5CG8PoYPR87wZciQlCd5R4bM.Q0_99ZuA3rasjrSP_rUVbFxe--Lgo-pJIlxsPJ9h1PoYD870nZC66sDYrA
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 21:00:00 | 397.55 | 213,909 | 1,190,341 |
| 20:59:59 | 397.59 | 76 | 976,432 |
| 20:59:59 | 397.56 | 69 | 976,356 |
| 20:59:59 | 397.56 | 116 | 976,287 |
| 20:59:59 | 397.45 | 60 | 976,171 |
| 20:59:58 | 397.47 | 80 | 976,111 |
| 20:59:58 | 397.43 | 40 | 976,031 |
| 20:59:58 | 397.43 | 40 | 975,991 |
| 20:59:58 | 397.38 | 56 | 975,951 |
| 20:59:58 | 397.42 | 100 | 975,895 |
Course Extremes
| 1 week | 387.03 | 433.3 | |
| 1 month | 387.03 | 479.79 | |
| Current year | 205.87 | 495.55 | |
| 1 year | 205.87 | 495.55 | |
| 3 years | 141.98 | 495.55 | |
| 5 years | 117.58 | 495.55 | |
| 10 years | 31.38 | 495.55 |
Monthly variations
Annual variations
| 2025 | +68.95% | ||
| 2024 | +22.94% | ||
| 2023 | -19.46% | ||
| 2022 | +40.14% | ||
| 2021 | +30.48% | ||
| 2020 | +12.85% | ||
| 2019 | +57.96% | ||
| 2018 | -42.61% | ||
| 2017 | +239.34% | ||
| 2016 | -60.23% | ||
| 2015 | -2.95% | ||
| 2014 | +50.86% | ||
| 2013 | +252.33% | ||
| 2012 | +123.93% | ||
| 2011 | -17.34% | ||
| 2010 | -44.04% | ||
| 2009 | -28.75% | ||
| 2008 | -14.96% | ||
| 2007 | +35.89% | ||
| 2006 | +60.18% | ||
| 2005 | +78.85% | ||
| 2004 | +24.29% |
- Stock Market
- Equities
- ALNY Stock
- Quotes Alnylam Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















